AC Immune (ACIU) Change in Receivables (2017 - 2025)
AC Immune (ACIU) posted quarterly Change in Receivables of $751953.0 for Q4 2025, down 97.32% year-over-year from $28.1 million in Q4 2024, and up 1974.17% quarter-over-quarter from $36253.2 in Q3 2025.
Powered by 
Analysis
AC Immune (ACIU) Change in Receivables (2017 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Change in Receivables for 8 consecutive years, with $751953.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Receivables fell 97.32% year-over-year to $751953.0; the TTM figure through Dec 2025 stood at $326140.6 (down 98.04% YoY), while the FY2025 annual figure was $217103.1, down 98.71% from the prior year.
- Change in Receivables advanced to $751953.0 in Q4 2025 per ACIU's latest filing, from $36253.2 in the prior quarter.
- Across five years, Change in Receivables topped out at $28.1 million in Q4 2024 and bottomed at -$28.4 million in Q3 2024.
- Historically, Change in Receivables has averaged $29721.1 across 5 years, with a median of $36253.2 in 2025.
- On a YoY basis, Change in Receivables climbed as much as 7713.21% in 2024 and fell as far as 24248.75% in 2024.
- AC Immune's Change in Receivables stood at $107471.4 in 2021, then plunged by 166.66% to -$71642.2 in 2022, then slumped by 23167.1% to -$16.7 million in 2023, then jumped by 268.46% to $28.1 million in 2024, then sank by 97.32% to $751953.0 in 2025.
- Business Quant data shows ACIU's Change in Receivables at $751953.0 in Q4 2025, $36253.2 in Q3 2025, and $485571.9 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 37.16 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 751,953.04 |
| Sep 30, 2025 | 36,253.18 |
| Jun 30, 2025 | 485,571.87 |
| Mar 31, 2025 | -947,637.46 |
| Dec 31, 2024 | 28.08 Mn |
| Sep 30, 2024 | -28.39 Mn |
| Mar 31, 2024 | 16.96 Mn |
| Dec 31, 2023 | -16.67 Mn |
| Sep 30, 2023 | -116,611.71 |
| Jun 30, 2023 | 328,091.79 |
| Mar 31, 2023 | -222,719.49 |
| Jun 30, 2022 | -71,642.22 |
| Mar 31, 2022 | 175,414.96 |
| Jun 30, 2021 | 107,471.42 |
| Mar 31, 2021 | -55,302.95 |
| Dec 31, 2019 | 2.69 Mn |
| Sep 30, 2019 | -1.92 Mn |
| Dec 31, 2018 | 701.20 Mn |
| Sep 30, 2018 | -330,326.46 |
| Dec 31, 2017 | -404.27 Mn |